Effect of Sage Extract Supplementation on Cognitive Function in Middle-Aged Men and Women
Condition(s) studied
Investigational drug(s) / intervention(s)
SageXtra: 333 mg/day of SageXtra sage extract powder in two #0 capsules (167 mg/capsule).
Placebo: 333 mg/day of methylcellulose powder in two #0 capsules.
Study summary
Sage (Salvia officinalis) has been reported to have antioxidant, anti-inflammatory, and neuroprotective properties. Several studies indicate that sage supplementation can improve cognitive function. However, more research is needed. The purpose of this study is to examine how sage supplementation affects cognitive function and reaction times in middle-aged men and women.
Eligibility
Primary outcome measure(s)
- COMputerized Mental Performance ASsessment System (COMPASS) Test Battery — 4 weeks and 8 weeks
COMPASS consists of seven components including; 1) Immediate and Delayed Word Recall, 2) Delayed Word Recognition, 3) Delayed Picture Recognition, 4) Corsi Blocks Task, 5) Digit Vigilance, 6) Stroop Test and, 7) Choice Reaction Time evaluated via a computer program.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Exercise & Sport Nutrition Lab - Texas A&M University | College Station | Texas | Recruiting |
More ESM Technologies, LLC trials in the USA
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07757529 on ClinicalTrials.gov ↗ ← All trials in the USA